Back to search

Article

B7H3 Targeting Gold Nanocage pH-Sensitive Conjugates for Precise and Synergistic Chemo-Photothermal Therapy against NSCLC

2023-06-06

Abstract excerpt

<h4>Background: </h4> The strategy of combining a drug delivery with an immune checkpoint target has been widely investigated in cancer therapy, but the remarkable benefit to patients from this strategy is still limited. B7 homolog 3 protein (B7-H3), also known as CD276 (B7-H3/CD276), is a promising anti-cancer therapeutic target that is broadly overexpressed on the surface of malignant cells and tumor vasculature...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9bc5a60a-a7e0-5845-ae5d-c409a983d58e
DOI
10.21203/rs.3.rs-3000523/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
B7H3 Targeting Gold Nanocage pH-Sensitive Conjugates for Precise and Synergistic Chemo-Photothermal Therapy against NSCLCDOI 10.21203/rs.3.rs-3000523/v1
Select a neighboring publication to make it the new centre.